Rx-To-OTC “Switchability” Initiation Rights May Require Legislation – Juhl
This article was originally published in The Tan Sheet
Executive Summary
Legislative action may be necessary to clarify who controls the Rx-to-OTC switch potential of a drug, University of Pittsburgh Vice Chancellor for Research Conduct & Compliance Randy Juhl, PhD, asserted
You may also be interested in...
Chronic Condition OTC Switches May Take Up To Seven Years – Consultant
Clinical studies of Rx-to-OTC switch candidates that target chronic conditions may take 12-24 months longer to conduct than traditional study regimens for acute OTCs, consultant Robert Boggs, PhD, Waife & Associates, observes
Chronic Condition OTC Switches May Take Up To Seven Years – Consultant
Clinical studies of Rx-to-OTC switch candidates that target chronic conditions may take 12-24 months longer to conduct than traditional study regimens for acute OTCs, consultant Robert Boggs, PhD, Waife & Associates, observes
Chronic Condition OTC Switches May Take Up To Seven Years – Consultant
Clinical studies of Rx-to-OTC switch candidates that target chronic conditions may take 12-24 months longer to conduct than traditional study regimens for acute OTCs, consultant Robert Boggs, PhD, Waife & Associates, observes